Mikra

Lifeist Reports Fourth Quarter 2023 Financial Results

Retrieved on: 
Tuesday, April 2, 2024
Growth, Science, Net, Bank statement, Mikra, Inventory, Self storage

Net revenue from continued operations of $4.7 million in Q4 2023 compared to $6.2 million in Q4 2022.

Key Points: 
  • Net revenue from continued operations of $4.7 million in Q4 2023 compared to $6.2 million in Q4 2022.
  • Operating costs and professional fees increased to $5.6 million in Q4 2023 compared to $5.5 million in Q4 2022.
  • Adjusted EBITDA loss improved to $5.0 million in Q4 2023 compared to $5.5 million in Q4 2022.
  • "Our performance in the fourth quarter of 2023 reflects our strategic focus on high-margin activities and operational efficiency, resulting in the highest quarterly gross profit in our company's history," said Meni Morim, CEO of Lifeist.

Lifeist Announces Results of Annual General and Special Meeting of Shareholders

Retrieved on: 
Wednesday, March 20, 2024
Remuneration, Science, Proxy, Sale, Public sector, Insurance, D&O, Drink, AGSM, Special, Mikra, Management

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced the results of the Company’s Annual General and Special Meeting of the shareholders held on March 14, 2024 (the “AGSM”).

Key Points: 
  • TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced the results of the Company’s Annual General and Special Meeting of the shareholders held on March 14, 2024 (the “AGSM”).
  • Clearhouse LLP, Chartered Public Accountants were appointed as the Company's auditor to hold office until the next annual meeting of shareholders or until its successor is duly appointed, at a remuneration to be fixed by the Board.
  • The special resolution for the proposed sale of the Company’s CannMart Group did not meet a super majority and therefore was not approved.
  • The proposed sale of the CannMart Group was intended to divest Lifeist of the continued negative cash flow that the cannabis business has cost shareholders since inception.

Mikra Reports Further Clinical Research that Validates Category-Defining Formulation of CELLF Cellular Health Supplement

Retrieved on: 
Thursday, February 15, 2024
Randomized controlled trial, Inflammation, Quality of life, Ageing, PQQ, Life, University, Coenzyme Q10, Attention, Oxidative stress, Mikra, Science, Human, Biochemistry, Dietary supplement

In younger adults (aged 20-40 years), PQQ improved cognitive function (cognitive flexibility, processing speed, and execution speed) after 8 weeks...

Key Points: 
  • In younger adults (aged 20-40 years), PQQ improved cognitive function (cognitive flexibility, processing speed, and execution speed) after 8 weeks...
  • Aimed at increasing glutathione and related defenses to improve health status and counteract aging processes in humans.
  • CELLF is a clinically validated formula proven to boost energy and focus on a cellular level, while protecting against the negative effects of oxidative stress.
  • Meticulously researched, the precision-engineered formula is designed to add healthy, energetic years to your life, so you can feel better, longer.

Lifeist Announces Sale of CannMart

Retrieved on: 
Friday, February 2, 2024
Growth, Science, Circular, News, Environment, Mikra, CAD, Transaction, Meeting, SPA, Sale, Procurement, Security (finance)

The projected final sale price for CannMart may thus exceed Lifeist’s total present market capitalization, resulting in extraordinarily attractive price-to-book and price-to-cash ratios for Lifeist post-closing.

Key Points: 
  • The projected final sale price for CannMart may thus exceed Lifeist’s total present market capitalization, resulting in extraordinarily attractive price-to-book and price-to-cash ratios for Lifeist post-closing.
  • "The decision to undertake this transaction is a pivotal step in our broader strategy to fortify the financial position of both Lifeist and CannMart by improving cash flow, streamlining operational costs, and strategically shifting the focus of both entities beyond the constraints of the current cannabis regulatory framework,” said Meni Morim, CEO of Lifeist.
  • Lifeist will focus on continuing the growth of its nutraceutical business Mikra and Aussie Vapes, while CannMart will benefit from operating away from the onerous demands imposed by the multilayered regulatory regime that governs Canadian public cannabis companies.
  • Kronos Capital Partners Inc. is acting as financial advisor to Lifeist in connection with the transaction.

Mikra to Introduce Innovative Immune Support Gummy

Retrieved on: 
Thursday, December 14, 2023
Powder, PROTECT, Science, Vitamin, Vitamin D, Zinc, Water, Mikra, Infection, Immunity, C2, Dietary supplement

“PROTECT is another example of our commitment to bringing science-backed natural solutions to market, marrying the antioxidant power of Aronia berries with the nutritional immune support of key vitamins, in the convenience of a gummy,” said Meni Morim, CEO of Lifeist. “As we head into cold and flu season, PROTECT can provide a defensive boost to immunity -- and unlike pills and powders, can be taken on the go without water. We invite new and loyal customers to sign up at https://bit.ly/mikra-december to receive an invitation for a free trial pack of Protect with their discounted promotional bundle.”

Key Points: 
  • Introduced by its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra"), Protect continues Lifeist's commitment to offering natural, science-backed solutions to its valued customers.
  • An exclusive preview of this innovative product is available for early subscribers who sign up for bundle promotions at https://bit.ly/mikra-december .
  • Protect comes in a tasty gummy format that combines the antioxidant power of Aronia berries1 with the reliable immune support functions of supplemental zinc and vitamin C2, complemented by vitamin D to tackle the shorter days in winter.
  • Its recent addition of two innovative natural products aligns with Mikra's commitment to reaching a wider audience and making their innovative products readily available to enhance wellness journeys.

Lifeist's Mikra Introduces Innovative New Mental Health Product and Provides Corporate Update

Retrieved on: 
Tuesday, September 26, 2023
Heart, Life, Marketing, Anxiety, Brain, Sale, Science, Growth, Mental health, Skin, Mikra, Pharmaceutical industry, Amazon

Mikra is pushing biosciences beyond the expected with the belief it is possible to add more valuable, enjoyable years to your life through rebuilding and protecting your cellular health.

Key Points: 
  • Mikra is pushing biosciences beyond the expected with the belief it is possible to add more valuable, enjoyable years to your life through rebuilding and protecting your cellular health.
  • "We are pleased to share an update on the continued progress of our U.S. biosciences subsidiary, Mikra Cellular Sciences Inc.,” said Meni Morim, CEO of Lifeist.
  • Toward that goal, we have developed a new supplement to help support mental wellness, a pressing global concern.
  • It is currently in the formulation finalization phase of achieving a proprietary supplement aimed at supporting mental health among those who wrestle with anxiety.

Lifeist Reports Second Quarter 2023 Financial Results

Retrieved on: 
Friday, July 28, 2023
Singular, Narrative, Diamond, Exercise, Inventory, Cannabis, Chroma, Human, LOT, Partnership, Marketing, Sugar, Initial, Gross income, Songwrights Apothecary Lab, Global health, Stock, Inflammation, GNC, Science, LP record, Athlete, Cordyceps, M&A, Flood, EBITDA, Investment, Acquisition, Amazon (company), Smoke, Growth, CFO, Ageing, Health, Mikra, Video game, Retail, Online shopping, Drug, Cryptocurrency, Distribution (marketing), Adjustment

TORONTO, July 28, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended May 31, 2023 (“Q2 2023”) compared to the same period last year (“Q2 2022”).

Key Points: 
  • TORONTO, July 28, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended May 31, 2023 (“Q2 2023”) compared to the same period last year (“Q2 2022”).
  • Net revenue for Q2 2023 increased 51% from the same quarter last year to $6.2 million compared to $4.1 million in Q2 2022.
  • "Our ongoing journey to transform Lifeist into a diversified wellness company with high-margin business units remains on track," affirmed Meni Morim, CEO of Lifeist.
  • "In our second quarter results, we experienced growth across all our key metrics, including achieving another historic high gross profit.